-
-
-
-
-
-
-
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
-
-
-
-
-
-
-
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
-
-
-
-
-
-
-
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
-
-
-
-
-
-
-
Aligos Therapeutics (ALGS) Presents Positive Data at the EASL Congress 2025
-
-
-
-
-
-
-
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024
-
1,208,306 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

